Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Carroll

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Cancer Cell|March 31, 2004
BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpointJamil Dierov, Raia Dierova, Martin Carroll
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 12, 2013
The oncogene eIF4E: using biochemical insights to target cancerMartin Carroll, Katherine L B Borden
Blood|February 8, 2007
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsDuonan Yu, Martin Carroll, Andrei Thomas-Tikhonenko
Blood|September 10, 2005
mTOR regulates cell survival after etoposide treatment in primary AML cellsQing Xu, James E Thompson, Martin Carroll
Midwives|June 7, 2014
Lack of healthcare information--a hidden killerSue Jacob, Martin Carroll, Neil Pakenham-Walsh
Current Oncology Reports|September 3, 2010
Targeted signal transduction therapies in myeloid malignanciesEmma Scott, Elizabeth Hexner, Alexander Perl, et al.
Blood|February 28, 2002
TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycleJamil Dierov, Qing Xu, Raia Dierova, et al.
Seminars in Hematology|November 14, 2024
A line in shifting sand: Can we define and target TP53 mutated MDS?Sarah Skuli, Andrew Matthews, Martin Carroll, et al.
Expert Review of Proteomics|September 25, 2015
Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsÖzlem Önder, Simone Sidoli, Martin Carroll, et al.
Cancer Cell|September 13, 2011
Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemiaGerd A Blobel, Anna Kalota, Patricia V Sanchez, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Cancer Cell|March 31, 2004
BCR/ABL translocates to the nucleus and disrupts an ATR-dependent intra-S phase checkpointJamil Dierov, Raia Dierova, Martin Carroll
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|March 12, 2013
The oncogene eIF4E: using biochemical insights to target cancerMartin Carroll, Katherine L B Borden
Blood|February 8, 2007
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsDuonan Yu, Martin Carroll, Andrei Thomas-Tikhonenko
Blood|September 10, 2005
mTOR regulates cell survival after etoposide treatment in primary AML cellsQing Xu, James E Thompson, Martin Carroll
Midwives|June 7, 2014
Lack of healthcare information--a hidden killerSue Jacob, Martin Carroll, Neil Pakenham-Walsh
Current Oncology Reports|September 3, 2010
Targeted signal transduction therapies in myeloid malignanciesEmma Scott, Elizabeth Hexner, Alexander Perl, et al.
Blood|February 28, 2002
TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycleJamil Dierov, Qing Xu, Raia Dierova, et al.
Seminars in Hematology|November 14, 2024
A line in shifting sand: Can we define and target TP53 mutated MDS?Sarah Skuli, Andrew Matthews, Martin Carroll, et al.
Expert Review of Proteomics|September 25, 2015
Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsÖzlem Önder, Simone Sidoli, Martin Carroll, et al.
Cancer Cell|September 13, 2011
Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemiaGerd A Blobel, Anna Kalota, Patricia V Sanchez, et al.
Pageof 13